Methotrexate-induced myelopathy mimicking subacute combined degeneration of the spinal cord

Pema, 1998, Myelopathy caused by nitrous oxide toxicity, Am J Neuroradiol, 19, 894

Teh, 2007, Transverse myelopathy following intrathecal administration of chemotherapy, Singapore Med J, 48, e46

Bay, 2005, Myelopathy due to intrathecal chemotherapy, J Pediatr Hematol Oncol, 27, 270, 10.1097/01.mph.0000162527.85024.e9

Bleyer, 1977, Clinical pharmacology of intrathecal methotrexate. Clinical pharmacology of intrathecal methotrexate. I. Pharmacokinetics in non toxic patients after lumbar injection, Cancer Treat Rep, 61, 703

Miller, 1989, Pharmacokinetics of methotrexate in cerebrospinal fluid after intracerebroventricular administration in patients with meningeal carcinomatosis and altered cerebrospinal fluid flow dynamics, Ther Drug Monit, 11, 231, 10.1097/00007691-198905000-00003

Ackermann, 2010, Methotrexate-induced myelopathy responsive to substitution of multiple folate metabolites, J Neurooncol, 97, 425, 10.1007/s11060-009-0028-9